The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

PFE FINANCIAL STATEMENTS

Pfizer Inc — balance sheet, income statement and cash flow trends

PFEPfizer Inc

🇺🇸 USA · US · Healthcare · Drug Manufacturers - General

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
050 B100 B2020202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue63.7 B $Gross Profit45.4 B $ · 71%Operating Income16 B $ · 25%Pre-tax Income4.2 B $ · 7%Net Income to Owners4.3 B $ · 7%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue63.7 B $-0.2%
Gross Profit45.4 B $+5.7%
Operating Income16 B $-15.4%
EBITDA12.6 B $-44.6%
Net Income to Owners4.3 B $-59.7%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0100 B200 B2020202120222023202420252026

Capital Structure

Q2 2026
Total Assets201.1 B
  • Equity85.2 B $42%
  • Current Liabilities32.6 B $16%
  • Long-term Liabilities83 B $41%

Key Figures

YoY change
Total Assets201.1 B $-2.4%
Total Liabilities115.6 B $-1.2%
Total Equity85.2 B $-4.0%
Cash & ST Investments11.7 B $-11.7%
Total Debt63.2 B $+2.3%
Net Debt62.2 B $+3.4%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
010 B20 B30 B2020202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
05 B10 B13.4 B $Operating-5.7 B $Investing-8.4 B $Financing-682 M $Net Change

Key Figures

YoY change
Operating Cash Flow13.4 B $-11.8%
Capital Expenditures2.4 B $-12.1%
Free Cash Flow11 B $-11.7%
Dividends Paid-9.8 B $-305.9%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on PFE

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.